Biotech ETFs invest in stocks of companies in the biotechnology industry, many of which are involved in the use of biological processes such as recombinant DNA technology, molecular biology, genetic engineering, and genomics.
* Assets and Average Volume as of 2022-05-19 16:17 EDT
Returns,
| Symbol | ETF Name | YTD | 1 Week | 1 Month | 1 Year | 3 Year | 5 Year | Returns Rating |
|---|---|---|---|---|---|---|---|---|
| IBB | iShares Biotechnology ETF | -24.56% | 5.10% | -9.50% | -22.72% | 11.66% | 19.38% | A |
| XBI | SPDR S&P Biotech ETF | -38.01% | 6.92% | -16.98% | -44.46% | -15.74% | -0.16% | B |
| ARKG | ARK Genomic Revolution ETF | -47.03% | 9.89% | -20.65% | -57.31% | 12.57% | 70.49% | N/A |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | -18.04% | 3.28% | -10.17% | -16.01% | 2.00% | 25.21% | A |
| LABU | Direxion Daily S&P Biotech Bull 3x Shares | -83.22% | 18.43% | -50.45% | -89.73% | -86.04% | -87.36% | N/A |
| BBH | VanEck Biotech ETF | -23.15% | 4.70% | -9.14% | -18.18% | 22.28% | 31.26% | A+ |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | -21.95% | 3.95% | -8.24% | -21.34% | 12.93% | 29.12% | A |
| IDNA | iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | -34.08% | 5.40% | -11.79% | -35.66% | N/A | N/A | N/A |
| GNOM | Global X Genomics & Biotechnology ETF | -39.85% | 6.89% | -13.98% | -42.00% | -13.54% | N/A | N/A |
| LABD | Direxion Daily S&P Biotech Bear 3x Shares | 120.82% | -22.36% | 37.69% | 122.55% | -87.49% | -97.01% | N/A |
| SBIO | ALPS Medical Breakthroughs ETF | -37.95% | 6.10% | -18.83% | -42.21% | -21.85% | 7.29% | N/A |
| BIB | ProShares Ultra Nasdaq Biotechnology | -42.15% | 10.79% | -21.64% | -42.42% | -0.59% | -1.74% | C+ |
| BTEC | Principal Healthcare Innovators ETF | -33.96% | 8.89% | -16.03% | -40.48% | -3.45% | 19.21% | N/A |
| IEIH | iShares Evolved U.S. Innovative Healthcare ETF | -9.18% | 2.45% | -6.37% | 0.28% | 41.55% | N/A | N/A |
| CNCR | Loncar Cancer Immunotherapy ETF | -39.88% | 5.73% | -15.03% | -47.87% | -23.90% | -30.02% | N/A |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | -49.23% | 6.59% | -21.23% | -57.80% | -29.51% | -10.74% | N/A |
| BBP | Virtus LifeSci Biotech Products ETF | -22.95% | 5.37% | -11.80% | -26.91% | -5.35% | 1.80% | N/A |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 46.59% | -10.66% | 19.98% | 30.45% | -60.97% | -72.91% | C |
| WDNA | WisdomTree BioRevolution Fund | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SaleBestseller No. 1
Extraordinary Things to Cut Out and Collage
- New Store Stock
- Rivan, Maria (Author)
- English (Publication Language)
- 208 Pages - 04/14/2020 (Publication Date) -...
SaleBestseller No. 2
800+ Vision Board Pictures and Quotes - Create Life Goals, Visualize, and Inspire with Magazine Clip Art and Collage Book
- Elevate Your Vision : An Enhanced Vision Board...
- Experience a new level of quality with our...
- Our vision board kit for women offers hand-picked,...
- Whether it’s a gift vision board for teens,...
- At Lamare, our mission is to help women plan and...
Bestseller No. 3
National Geographic Wonders of the World: Earth's Most Awesome Places
- National Geographic Special - 2017-1-20 SIP...
- English (Publication Language)
- 128 Pages - 01/20/2017 (Publication Date) -...
Fund Flows,
Subscribe to get access
Read more of this content when you subscribe today.
Bestseller No. 1
A Calamity of Souls
- Amazon Kindle Edition
- Baldacci, David (Author)
- English (Publication Language)
- 487 Pages - 04/16/2024 (Publication Date) - Grand...
Bestseller No. 2
The Women: A Novel
- Amazon Kindle Edition
- Hannah, Kristin (Author)
- English (Publication Language)
- 472 Pages - 02/06/2024 (Publication Date) - St....
Bestseller No. 3
First Lie Wins: Reese's Book Club Pick (A Novel)
- Amazon Kindle Edition
- Elston, Ashley (Author)
- English (Publication Language)
- 348 Pages - 01/02/2024 (Publication Date) - Pamela...
Expenses